Search

Displaying results 2751 - 2760 of 10000 in total
  1. Drug

    Fanregratinib

    go.drugbank.com/drugs/DB21688
    Experimental

    Fanregratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Fanregratinib is a fibroblast growth factor receptor (FGFR) inhibitor.

  2. Drug

    Ilantimod

    go.drugbank.com/drugs/DB21742
    Experimental

    Ilantimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Ilantimod is a immunomodulator, both stimulant/suppressive and stimulant.

  3. Drug

    Calcium saccharate

    go.drugbank.com/drugs/DB13962
    ApprovedWithdrawn

    Pharmaceutic Aid (Stabilizer)

    Mixtures: CALCIUM GLUCONATE INJECTION USP 10%
  4. Drug

    Natural Killer Cell

    go.drugbank.com/drugs/DB15721
    Investigational

    It is also possible to culture UCB CD34+ hematopoietic stem cells (HSCs) under stimulation of IL-2, IL-15, and stem cell factor (SCF) in a system to develop NK cells. … Induced pluripotent stem cells (iPSCs) and human embryonic stem cells (HESCs) are also used to generate NK cells through a two-step culture method resulting in CD34+ cells.

  5. Drug

    Anti-CD7 CAR-T

    go.drugbank.com/drugs/DB23322
    Investigational

    CD7 CAR-T is a biologic drug. CD7 CAR-T is under investigation in clinical trial NCT07117305 (CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation).

  6. Drug

    Riltozinameran

    go.drugbank.com/drugs/DB17095
    ApprovedInvestigational

    [L43917] As of November 2022, it is the primary circulating variant of concern according to the World Health Organization. … [L43917] Riltozinameran is an mRNA vaccine encoding the S glycoprotein of SARS-CoV-2 Omicron variant lineage BA.1.

  7. Drug

    Anakinra

    go.drugbank.com/drugs/DB00026
    ApprovedInvestigational

    A few studies have evaluated the use of anakinra for the treatment of coronavirus disease 2019 (COVID-19). … [L35415] Anakinra is indicated for the management of rheumatoid arthritis (RA) in patients 18 years of age or older who have failed one or more disease-modifying antirheumatic drugs (DMARDs), as well as

  8. Drug

    Metyrapone

    go.drugbank.com/drugs/DB01011
    ApprovedInvestigational

    It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of cushing syndrome.

  9. Drug

    Sodium zirconium cyclosilicate

    go.drugbank.com/drugs/DB14048
    ApprovedInvestigational

    [L2933] The treatment effect was maintained for up to 12 months.[L2933] … [L2933] It is administered orally and is odorless, tasteless, and stable at room temperature.

  10. Drug

    Thonzonium

    go.drugbank.com/drugs/DB09552
    Approved

    It is widely used as an additive to in ear and nasal drops to enhance dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of the administered medication. … A common pharmaceutical formulation of thonzonium bromide is cortisporin-TC ear drops. It is also reported that thonzonium also confers an antifungal property and antiresorptive effect on bone.

    Mixtures: Coly-Mycin S, Coly-Mycin S